Dietary intake of glucoraphanin during pregnancy and lactation prevents the behavioral abnormalities in the offspring after maternal immune activation
Abstract Aim Epidemiological data suggest that maternal immune activation (MIA) plays a role in the etiology of neuropsychiatric disorders including autism spectrum disorder (ASD) and schizophrenia. However, there is no prophylactic nutrition that can prevent the onset of neurodevelopmental disorder...
Saved in:
Main Authors: | Yuko Fujita (Author), Atsuhiro Fujita (Author), Tamaki Ishima (Author), Ayumi Hirai (Author), Shigenori Suzuki (Author), Hiroyuki Suganuma (Author), Kenji Hashimoto (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP
by: Yaoyu Pu, et al.
Published: (2019) -
Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)‐ketamine, but not (S)‐ketamine
by: Yuko Fujita, et al.
Published: (2020) -
Bioactivated Glucoraphanin Modulates Genes Involved in Necroptosis on Motor-Neuron-like Nsc-34: A Transcriptomic Study
by: Aurelio Minuti, et al.
Published: (2024) -
Glucoraphanin Triggers Rapid Antidepressant Responses in a Rat Model of Beta Amyloid-Induced Depressive-like Behaviour
by: Paolo Tucci, et al.
Published: (2022) -
Evaluation of dietary intake of lactating women in China and its potential impact on the health of mothers and infants
by: Chen Haijiao, et al.
Published: (2012)